Search

everythinglearnresearchcommunity

for

Search:↓

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Certain zinc transporters are essential for healthy skin and managing zinc in the body could help treat skin problems.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

PRP shows promise for skin rejuvenation but needs more research.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Blocking interferon-gamma might help treat various autoimmune diseases.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.